Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Other financing activities: 2021-2024

Historic Other financing activities for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Dec 2024 value amounting to -$5.3 million.

  • Centessa Pharmaceuticals' Other financing activities was N/A to $4.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$6.0 million, marking a year-over-year change of. This contributed to the annual value of -$5.3 million for FY2024, which is N/A change from last year.
  • Per Centessa Pharmaceuticals' latest filing, its Other financing activities stood at -$5.3 million for FY2024, which was down 1,937.55% from -$261,000 recorded in FY2022.
  • Centessa Pharmaceuticals' Other financing activities' 5-year high stood at -$261,000 during FY2022, with a 5-year trough of -$5.3 million in FY2024.
  • Over the past 2 years, Centessa Pharmaceuticals' median Other financing activities value was -$2.8 million (recorded in 2022), while the average stood at -$2.8 million.
  • Data for Centessa Pharmaceuticals' Other financing activities shows a peak YoY rose of 11.53% (in 2022) over the last 5 years.
  • Centessa Pharmaceuticals' Other financing activities (Yearly) stood at -$295,000 in 2021, then increased by 11.53% to -$261,000 in 2022, then reached -$5.3 million in 2024.